Literature DB >> 12940880

Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder.

Fiona J Warner1, Robert C Miller, Elizabeth Burcher.   

Abstract

1. The present study compared the binding and functional characteristics of tachykinin NK2 receptors in human detrusor muscle with those in human colon circular muscle. 2. In radioligand binding studies, similar KD values were observed for tachykinin NK2 receptor radioligands [125I]-neurokinin (NK) A, [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10,]NKA(4-10) and [3H]-SR48968 in both human colon circular muscle (0.28-1.1 nmol/L) and human bladder detrusor (0.49-0.91 nmol/L), suggesting binding was primarily to tachykinin NK2 receptors. Receptor capacity (Bmax) was greater in colon compared with detrusor muscle. 3. In functional studies of isolated smooth muscle contraction, there was an excellent positive correlation between human bladder detrusor and colon circular muscle with respect to in vitro contractile potency (r = 0.97) and maximum responses (r = 0.98) to tachykinins, selective tachykinin receptor ligands and l-Ala-substituted NKA(4-10) analogues. 4. Species differences between the human and rat tachykinin NK2 receptors were apparent as observed by a low correlation for potency (r = 0.77) and efficacy (r = 0.32) of l-Ala-substituted analogues in isolated smooth muscle contractile studies. 5. Minor differences observed in the affinity and potency of NK2 receptor agonists between colon and bladder are dependent on the tissue of interest, the receptor-effector coupling and the presence of other tachykinin receptors. Overall, the NK2 receptors of human colon and urinary bladder smooth muscle appear pharmacologically identical.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940880     DOI: 10.1046/j.1440-1681.2003.03887.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  10 in total

1.  Colorectal and cardiovascular effects of [Lys5,MeLeu9,Nle10]-NKA(4-10) in anesthetized macaques.

Authors:  Nadia M J Rupniak; Mary Katofiasc; Edward C Burgard; Karl B Thor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-01       Impact factor: 3.000

2.  NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs.

Authors:  Nadia M J Rupniak; Mary Katofiasc; Lesley Marson; Karl B Thor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-26       Impact factor: 3.000

3.  Chronic, Twice-Daily Dosing of an NK2 Receptor Agonist [Lys5,MeLeu9,Nle10]-NKA(4-10), Produces Consistent Drug-Induced Micturition and Defecation in Chronic Spinal Rats.

Authors:  Lesley Marson; Raymond Keast Piatt; Mary A Katofiasc; Carol Bobbitt; Karl B Thor
Journal:  J Neurotrauma       Date:  2019-11-13       Impact factor: 5.269

4.  Pharmacodynamic evaluation of Lys5, MeLeu9, Nle10-NKA(4-10) prokinetic effects on bladder and colon activity in acute spinal cord transected and spinally intact rats.

Authors:  F Aura Kullmann; M Katofiasc; K B Thor; Lesley Marson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-26       Impact factor: 3.000

5.  Prokinetic effects of neurokinin-2 receptor agonists on the bladder and rectum of rats with acute spinal cord transection.

Authors:  Lesley Marson; Karl B Thor; Mary Katofiasc; Edward C Burgard; Nadia M J Rupniak
Journal:  Eur J Pharmacol       Date:  2017-12-10       Impact factor: 4.432

6.  MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome.

Authors:  Veronica Sanchez Freire; Fiona C Burkhard; Thomas M Kessler; Annette Kuhn; Annette Draeger; Katia Monastyrskaya
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Bladder smooth muscle strip contractility as a method to evaluate lower urinary tract pharmacology.

Authors:  F Aura Kullmann; Stephanie L Daugherty; William C de Groat; Lori A Birder
Journal:  J Vis Exp       Date:  2014-08-18       Impact factor: 1.355

Review 8.  Role of neurogenic inflammation in local communication in the visceral mucosa.

Authors:  Lori A Birder; F Aura Kullmann
Journal:  Semin Immunopathol       Date:  2018-03-26       Impact factor: 9.623

9.  Current Knowledge and Novel Frontiers in Lower Urinary Tract Dysfunction after Spinal Cord Injury: Basic Research Perspectives.

Authors:  Naoki Wada; Sergei Karnup; Katsumi Kadekawa; Nobutaka Shimizu; Joonbeom Kwon; Takahiro Shimizu; Daisuke Gotoh; Hidehiro Kakizaki; William C de Groat; Naoki Yoshimura
Journal:  Urol Sci       Date:  2022-08-25

10.  Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors.

Authors:  Nadia M J Rupniak; Elisabetta Perdona; Cristiana Griffante; Palmina Cavallini; Anna Sava; Daniel J Ricca; Karl B Thor; Edward C Burgard; Mauro Corsi
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.